If you're having trouble viewing this email, see it on the Web.
Technet21

Home | Invite Others | Digest Archives  
Posts:

technet21 postspacerIntradermal Influenza Vaccine

technet21 postspacerIntradermal Influenza Vaccination Superior than IM

technet21 postspacerJob Vacancy: Technical Officer, Vaccine Access and Delivery
Issue 22, 28 September 2009
 
Editorial Note

Intradermal vaccines dominate this issue of the Digest, with two posts by Omesh Bharti on the subject. The web highlights includes a link to a related article on microneedle-based vaccines.

From Joseph Little, we have a new job announcement for PATH.


by Omesh Bharti

After Virorab, Sanofi-Pasteur has come out with a low-cost intradermal Influenza vaccine.

[Read more]

Comment on this post by email or on the web

by Omesh Bharti

The government of India is importing 2.8 million doses of H1N1 vaccine, but it can come down to 0.7-0.8 million doses if they try for the intradermal route.

[Read more]

Comment on this post by email or on the web

by Joseph Little

PATH seeks a Technical Officer with experience in supply chain management and logistics to support research and demonstration of new and innovative systems, technologies, and practices for the vaccine supply chain in Senegal. Under the guidance and direction of the Optimize Project Coordinator, and in collaboration with the global Optimize team, duties and responsibilities include ...

[Read more]

Comment on this post by email or on the web
Photo Courtesy: ITPI

  Web Highlights:
  technet21 post Microneedle-based vaccines
  technet21 post Merck, Qiagen pledge cervical cancer tools at CGI
  technet21 post Benefit and doubt in vaccine additive
  technet21 post Merck, Wellcome Trust to launch vaccine center in India
  technet21 post Investigational vaccine shows modest potential for protecting against HIV infection

Register

If you have contributions to make or thoughts to share with others on TechNet21, you can write to the moderator or post directly on the web forums. Click here to change your subscription settings or unsubscribe from the mailing list.

TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.

For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.